Dr Rob Cooper
About Dr Rob Cooper
Responsibilities at LHCH
Consultant Cardiologist with a specialist interest in Inherited Cardiac Conditions and Cardiac MRI.
Special clinical interests
- Management of patients with all types of Cardiomyopathies.
- Specific interest in the treatment of patients with Hypertrophic Obstructive Cardiomyopathy (HOCM).
- Genetic basis of cardiac disease.
- All types of Cardiac MRI, including; Cardiomyopathies, Congenital Heart Disease, Ischaemic and valvular heart disease.
- Treatment of Obstruction in Hypertrophic Cardiomyopathy; Alcohol Septal Ablation (ASA), surgical myectomy and direct radiofrequency ablation.
- Differentiation of the athlete’s heart from Cardiomyopathy.
- Exercise in hypertrophic Cardiomyopathy.
- Genetic basis of cardiac disease including the 100,000 Genome Project.
- Use of 3D printing to guide personalised structural intervention in Cardiology.
Regional and National responsibilities:
- Clinical Genomic Interpretation Partner (GeCIP) for 100,000 genome project.
Current membership of professional regional and national bodies:
- Association for Inherited Cardiac Conditions
- European Cardiovascular Imaging Society
- British Society of Cardiovascular Magnetic Resonance
- British Society for Cardiovascular Imaging
- British Society of Echocardiography
- British Cardiac Society
- Royal College of Physicians
I have published mainly in the field of heart muscle disease, this includes 2 textbook chapters, 11 review articles, 15 original research papers, 28 abstracts and 16 case reports/series. These can be accessed via pubmed or ResearchGate.
Recent selected publications include:
- New developments in hypertrophic cardiomyopathy; Robert M Cooper, Claire Raphael, Max Liebregts, Josef Veselka; The Canadian Journal of Cardiology Jul 2017
- Non-surgical septal reduction therapy in hypertrophic cardiomyopathy; Cooper RM, Stables RH; Heart. 2017 Sep 7.
- Intervention in HCM; Patient selection, procedural approach and emerging techniques in alcohol septal ablation; R M Cooper, A Shahzad, R H Stables; Echo Research and Practice March 2015 2:R25-R35
- Radiofrequency ablation of the interventricular septum to treat outflow tract gradients in hypertrophic obstructive cardiomyopathy: A novel use of CARTOsound technology to guide ablation; R M Cooper, S Modi, A Shahzad, J Hasleton, J DiGiovanni, M Hall, D Todd, R H Stables; Europace 18(1):113-120 · January 2016
- Computed Tomography angiography planning identifies the target vessel for optimum infarct location and improves clinical outcome in alcohol septal ablation for hypertrophic obstructive cardiomyopathy; R M Cooper, S Binukrishnan, A Shahzad, J Hasleton, U Sigwart, R H Stables; Eurointervention 12(18) · November 2016
- Outcome of Alcohol Septal Ablation in Mildly Symptomatic Patients With Hypertrophic Obstructive Cardiomyopathy: A Long-Term Follow-Up Study Based on the Euro-Alcohol Septal Ablation Registry; Veselka J, Faber L, Liebregts M, Cooper R M, Januska J, Krejci J, Bartel T, Dabrowski M, Hansen PR, Almaas VM, Seggewiss H, Horstkotte D, Adlova R, Bundgaard H, Ten Berg J, Stables RH, Jensen MK; Journal of the American Heart Association 2017 May 16;6(5)
- Mechanisms of myocardial ischaemia in Hypertrophic Cardiomyopathy; Claire E Raphael, R M Cooper, H Parker, J Collinson, V Vassilou, A Ali, D Pennell, R DeSilva, LYueh Hsu, A M Greve, S Nijjer, C Broyd, J Keegan, J Davies, A Hughes, A Arai, M Frennaux, R H Stables, C DiMario, S K Prasad; Journal of the American College of Cardiology 68(15) · October 2016
I graduated from the University of Liverpool with Honours in 2005, during my undergraduate years I spent time training in the Netherlands. I completed postgraduate training in Medicine and Cardiology in the Mersey Deanery during the period 2005-2017. In this time I completed a PhD in the management of patients with Hypertrophic Cardiomyopathy.
I undertook additional training in inherited cardiac conditions and Cardiac MRI during a fellowship at the Royal Brompton Hospital in London and have spent time in Inherited Cardiac Conditions services in Oxford and Copenhagen.
I am involved strategic planning for Genomic Medicine in Cardiology on Merseyside and I serve as a Genomic Clinical Interpretation Partner as part of the 100,000 Genome Project.
Why choose LHCH?
LHCH provides excellent, first class care for patients with inherited cardiovascular conditions. This is achieved in a friendly environment with the patient firmly at the centre of every model.
I am married with 2 sons. Most of my hobbies now include fairly boring exercise but I was once half decent at tennis and football.